VolitionRx Limited (VNRX) Operating cash flow 2016–2025
VolitionRx Limited (VNRX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$19.7MFY2025 · since FY2016: -$8.9M → -$19.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$19.7M | +24.0% |
| FY2024 | -$25.9M | -43.4% |
| FY2023 | -$18.1M | -18.2% |
| FY2022 | -$15.3M | +26.7% |
| FY2021 | -$20.9M | -26.7% |
| FY2020 | -$16.5M | -29.2% |
| FY2019 | -$12.7M | +13.5% |
| FY2018 | -$14.7M | -20.8% |
| FY2017 | -$12.2M | -37.5% |
| FY2016 | -$8.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More VNRX financial trends
VNRX RevenueVNRX Net incomeVNRX Net marginVNRX Gross profitVNRX Gross marginVNRX Operating incomeVNRX Operating marginVNRX Free cash flowVNRX Capital expendituresVNRX Return on equityVNRX Stock buybacksVNRX Dividends paidVNRX Total assetsVNRX Total liabilitiesVNRX Shareholders’ equityVNRX overview →